Latest Licensing News

Neuren Pharmaceuticals has secured a pivotal FDA Type C Meeting to discuss primary efficacy endpoints for its Phase 3 trial of NNZ-2591 targeting Phelan-McDermid syndrome, advancing its rare disease drug development.

Lindian Resources has awarded a $1.3 million contract to Mota-Engil for the construction of a critical access road at its Kangankunde Rare Earths Project in Malawi, marking a key milestone in project development and local infrastructure enhancement.

Blackstone Minerals is set to merge with IDM International, combining expertise and local presence to advance exploration of the world-class Mankayan copper-gold porphyry project in the Philippines.

Arizona Lithium has unveiled a detailed, phased development plan for its Prairie Lithium Project, aiming to become North America’s first commercial lithium brine producer. The company targets initial production in 2025 with a modest capital outlay and scalable expansion strategy.

Blackstone Minerals has entered a binding scheme to acquire IDM International, securing the world-class Mankayan Copper-Gold Project in the Philippines. This merger positions Blackstone as a significant player in critical energy transition metals with promising exploration upside.

AdAlta has fast-tracked its cellular immunotherapy growth by signing two new term sheets for clinical-stage CAR-T products from Asia, pivoting to focus on in-licensing and clinical trials while winding down internal R&D on its antifibrotic drug AD-214.

Krakatoa Resources has identified significant potential extensions of antimony and gold mineralisation at its Zopkhito Project in Georgia, supported by advanced induced polarisation modelling. The company is poised to advance exploration with drilling and resource estimation in 2025.

Neurizon Therapeutics has been granted a pivotal US patent for its lead drug candidate NUZ-001, extending protection until 2039 and enhancing its commercial and clinical positioning in neurodegenerative disease treatment.

Audeara Limited has landed a significant US$917,000 follow-up purchase order from a global music instrument manufacturer, reinforcing the commercial viability of its hearing technology and expanding its licensing footprint.

Meteoric Resources reports exceptional rare earth element grades and enriched magnetic rare earth oxides at its Agostinho Prospect in Brazil, signaling a potential expansion of its Caldeira Project resource base.

Evion Group has successfully raised $1.33 million through a rights issue, positioning itself to accelerate production at its Panthera JV in India. The company also announced a bonus options offer to reward shareholders and support future expansion.

Bio-Gene Technology Limited has secured A$3 million in U.S. Department of Defense grants to accelerate development of its two nature-derived insecticides, Flavocide and Qcide, targeting both military and civilian markets.